Pharmaceutical consultants apply their comprehensive expertise in different areas to accelerate the drug development process.

Promising Nonalcoholic Steatohepatitis Therapies such as AZD2693, Saroglitazar Magnesium 4 mg, Semaglutide (SEMA), Cilofexor ...

Vericel's FDA-approved regenerative medicine products and robust pipeline signal strong growth potential, with zero debt and ...

The acquisition is expected to enhance Jazz's oncology portfolio by adding dordaviprone, a novel small molecule therapy in ...

"The FDA IND clearance of MRANK-106 is a significant milestone for MindRank and validates the potential of our AI-driven approach to drug discovery. As the company's second clinical-stage pipeline ...

Despite the small patient population, which has scared away some drug developers, Jazz sees an opportunity. If the deal is completed and the FDA approves ... which had three development programs.

Nuvation Bio has secured $250m in non-dilutive financing from Sagard, aimed at funding the commercialisation of taletrectinib ...

Annual net revenue increased 4% to $267.0 million in 2024, despite significant divestitures –– UDENYCA® net revenue increased 62% ...

Laekna is actively exploring partnerships to accelerate the clinical development ... of our drug candidate assets. We keep advancing and expanding our pipeline and are committed to bringing ...

In March 2025, Akeso initiated an open-label, Phase Ib/II study involving patients diagnosed with acute myeloid leukemia (AML ...